11/10
11:09 am
lmat
LeMaitre Vascular (NASDAQ:LMAT) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald.
11/7
01:55 pm
lmat
Rating for LMAT
Low
Report
Rating for LMAT
11/7
01:55 pm
lmat
Rating for LMAT
Low
Report
Rating for LMAT
11/5
12:56 pm
lmat
LeMaitre Vascular (NASDAQ:LMAT) had its "buy" rating reaffirmed by analysts at Roth Capital. They now have a $108.00 price target on the stock.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) had its "buy" rating reaffirmed by analysts at Roth Capital. They now have a $108.00 price target on the stock.
11/5
12:56 pm
lmat
LeMaitre Vascular (NASDAQ:LMAT) had its "buy" rating reaffirmed by analysts at Roth Capital. They now have a $108.00 price target on the stock.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) had its "buy" rating reaffirmed by analysts at Roth Capital. They now have a $108.00 price target on the stock.
11/5
12:28 pm
lmat
Rating for LMAT
Low
Report
Rating for LMAT
11/5
12:28 pm
lmat
Rating for LMAT
Low
Report
Rating for LMAT
10/15
08:12 am
lmat
LeMaitre Vascular (NASDAQ:LMAT) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $95.00 price target on the stock.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $95.00 price target on the stock.
10/15
07:47 am
lmat
Rating for LMAT
Low
Report
Rating for LMAT
9/23
11:51 am
lmat
LeMaitre Vascular (NASDAQ:LMAT) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $95.00 price target on the stock.
Low
Report
LeMaitre Vascular (NASDAQ:LMAT) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $95.00 price target on the stock.
9/23
11:14 am
lmat
Rating for LMAT
Low
Report
Rating for LMAT